{"disease":{"id":"anaplastic-lymphoma-kinase-gene-translocation","name":"anaplastic lymphoma kinase gene translocation"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT05525338","title":"Comparison of Standard Dose Alectinib to Alectinib in Adjusted Dose Based on Alectinib Bloodlevels","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":196,"lead_sponsor_name":"University Medical Center Groningen","has_results":false},{"nct_id":"NCT04881916","title":"Immune and Genomic Markers in ALK+ NSCLC","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false},{"nct_id":"NCT04292119","title":"Lorlatinib Combinations in Lung Cancer","phase":"PHASE1, PHASE2","overall_status":"UNKNOWN","enrollment_count":96,"lead_sponsor_name":"Massachusetts General Hospital","has_results":false}],"total":3},"guidelines":[],"source":"Drug Landscape verified database"}